I believe they will shake the tree so that cheap shares fall into their hands and then sell when there is a spike. And then do it again. The pps has also been effected by naked shorting, retail investors selling for a profit on the last spike, ongoing dilution and potential dilution. I do believe that the Phase two starting, the animal studies, blood program, moving to Nasd, and a JV for one of the programs is not that far down the road. I also believe that mgt will try to limit dilution as best they can --one reason being to keep their ownership percentage in tact. All imhoglta
